ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 44 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,142 | -87.3% | 2,464 | -96.8% | 0.00% | – |
| Q2 2023 | $24,746 | -60.8% | 75,907 | -48.3% | 0.00% | – |
| Q1 2023 | $63,095 | +104.9% | 146,733 | +152.5% | 0.00% | – |
| Q4 2022 | $30,795 | -51.9% | 58,104 | -34.6% | 0.00% | – |
| Q3 2022 | $64,000 | -36.6% | 88,818 | +0.2% | 0.00% | – |
| Q2 2022 | $101,000 | -17.9% | 88,606 | +49.1% | 0.00% | – |
| Q1 2022 | $123,000 | +20.6% | 59,434 | +67.4% | 0.00% | – |
| Q4 2021 | $102,000 | -32.5% | 35,498 | -0.9% | 0.00% | – |
| Q3 2021 | $151,000 | -18.8% | 35,834 | +1.4% | 0.00% | – |
| Q2 2021 | $186,000 | +38.8% | 35,328 | +22.1% | 0.00% | – |
| Q1 2021 | $134,000 | +1575.0% | 28,928 | +1071.2% | 0.00% | – |
| Q4 2020 | $8,000 | +60.0% | 2,470 | +50.7% | 0.00% | – |
| Q3 2020 | $5,000 | -66.7% | 1,639 | -63.0% | 0.00% | – |
| Q2 2020 | $15,000 | -82.6% | 4,431 | -80.2% | 0.00% | – |
| Q1 2020 | $86,000 | -41.5% | 22,324 | -8.4% | 0.00% | – |
| Q4 2019 | $147,000 | +19.5% | 24,375 | +49.4% | 0.00% | – |
| Q3 2019 | $123,000 | +115.8% | 16,317 | +288.0% | 0.00% | – |
| Q2 2019 | $57,000 | +470.0% | 4,205 | +110.1% | 0.00% | – |
| Q1 2019 | $10,000 | +25.0% | 2,001 | -29.5% | 0.00% | – |
| Q4 2018 | $8,000 | -88.2% | 2,839 | -65.8% | 0.00% | – |
| Q3 2018 | $68,000 | -87.9% | 8,306 | -85.6% | 0.00% | – |
| Q2 2018 | $563,000 | +56.4% | 57,821 | +39.6% | 0.00% | – |
| Q1 2018 | $360,000 | -17.1% | 41,414 | +19.6% | 0.00% | – |
| Q4 2017 | $434,000 | +52.3% | 34,632 | +1.6% | 0.00% | – |
| Q3 2017 | $285,000 | +1800.0% | 34,079 | +3759.5% | 0.00% | – |
| Q2 2017 | $15,000 | +7.1% | 883 | +29.3% | 0.00% | – |
| Q1 2017 | $14,000 | 0.0% | 683 | -23.0% | 0.00% | – |
| Q4 2016 | $14,000 | +100.0% | 887 | +77.4% | 0.00% | – |
| Q3 2016 | $7,000 | +600.0% | 500 | +400.0% | 0.00% | – |
| Q2 2016 | $1,000 | -66.7% | 100 | -71.8% | 0.00% | – |
| Q1 2016 | $3,000 | +200.0% | 354 | +230.8% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 107 | -6.1% | 0.00% | – |
| Q3 2015 | $1,000 | – | 114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 4,898,927 | $6,246,132 | 0.70% |
| Yakira Capital Management, Inc. | 620,019 | $790,524 | 0.22% |
| Crystalline Management Inc. | 230,817 | $294,292 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 475,000 | $605,625 | 0.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,283,979 | $2,912,073 | 0.12% |
| PenderFund Capital Management Ltd. | 123,444 | $213 | 0.06% |
| FIFTH LANE CAPITAL, LP | 100,000 | $127,000 | 0.04% |
| CSS LLC/IL | 476,831 | $607,960 | 0.04% |
| Penserra Capital Management LLC | 220,858 | $280 | 0.01% |
| King Wealth Management Group | 16,000 | $20 | 0.00% |